Zenas BioPharma, Inc. (ZBIO) Reports Q1 Loss of $0.80

Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q1 EPS of ($0.80). Revenue for the quarter came in at $10 million.

For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Increasing unusual option volume: GPRO JXN ALMS ALLY RSI PCG GTLB OLLI BAM
• Marriott Vacations Worldwide (VAC) Declares $0.80 Quarterly Dividend; 3.2% Yield